Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared on LinkedIn:
“Everyone has been asking about the new pill for pancreas cancer.
The story is bigger. While not a cure, it opens the door for treatments for RAS-driven cancers including colorectal, lung, and beyond. Results and activity is phenomenal.
Gave 2 talks in Seattle.”
You can also read: Phase 3 RASolute 309 Trial Begins: RASONQUE Plus Zoldonrasib in First-Line RAS G12D PDAC
